Catalent Inc (CTLT)
56.36
-0.17
(-0.30%)
USD |
NYSE |
May 08, 12:37
Catalent Shareholders Equity (Quarterly): 3.687B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.687B |
| September 30, 2023 | 3.841B |
| June 30, 2023 | 4.611B |
| March 31, 2023 | 4.703B |
| December 31, 2022 | 4.912B |
| September 30, 2022 | 4.70B |
| June 30, 2022 | 4.775B |
| March 31, 2022 | 4.632B |
| December 31, 2021 | 4.481B |
| September 30, 2021 | 4.38B |
| June 30, 2021 | 4.274B |
| March 31, 2021 | 4.072B |
| December 31, 2020 | 3.814B |
| September 30, 2020 | 3.679B |
| June 30, 2020 | 3.506B |
| March 31, 2020 | 2.794B |
| December 31, 2019 | 2.323B |
| September 30, 2019 | 2.256B |
| June 30, 2019 | 2.288B |
| March 31, 2019 | 1.621B |
| December 31, 2018 | 1.563B |
| September 30, 2018 | 1.529B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.087B |
| March 31, 2018 | 1.068B |
| December 31, 2017 | 1.006B |
| September 30, 2017 | 1.039B |
| June 30, 2017 | 723.50M |
| March 31, 2017 | 642.70M |
| December 31, 2016 | 588.00M |
| September 30, 2016 | 614.50M |
| June 30, 2016 | 635.90M |
| March 31, 2016 | 602.90M |
| December 31, 2015 | 607.40M |
| September 30, 2015 | 597.20M |
| June 30, 2015 | 634.00M |
| March 31, 2015 | 468.20M |
| December 31, 2014 | 493.30M |
| September 30, 2014 | 503.80M |
| June 30, 2014 | -371.20M |
| March 31, 2014 | -400.00M |
| December 31, 2013 | -414.10M |
| September 30, 2013 | -386.90M |
| June 30, 2013 | -410.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.256B
Minimum
Sep 2019
4.912B
Maximum
Dec 2022
3.880B
Average
4.072B
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 12.81B |
| Merck & Co Inc | 40.36B |
| Elanco Animal Health Inc | 6.223B |
| Amgen Inc | 5.022B |
| Avrobio Inc | 94.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.988B |
| Total Liabilities (Quarterly) | 6.301B |
| Debt to Equity Ratio | 1.358 |
| Current Ratio | 2.481 |
| Net Debt Paydown Yield | -1.97% |